CRL240816C280000
- 14.79
- 0.000.00%
Charles River Newsroom
Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
Stephens Adjusts Price Target on Charles River Laboratories International to $250 From $280
Charles River (CRAI) Stock Rises 76% Year to Date: Here's How
Those Who Invested in Charles River Laboratories International (NYSE:CRL) Five Years Ago Are up 50%
Charles River Laboratories International, Inc.'s (NYSE:CRL) Intrinsic Value Is Potentially 31% Above Its Share Price
Is Charles River Associates (CRAI) Outperforming Other Business Services Stocks This Year?
Apple To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday
Express News | Baird Maintains Outperform on Charles River, Lowers Price Target to $239
Baird Maintains Charles River(CRL.US) With Buy Rating, Cuts Target Price to $239
Drug Middlemen Pay Higher Prices to Their Own Pharmacies, Says FTC
Express News | Charles River Laboratories International Inc : Baird Cuts Target Price to $239 From $271
Evercore Maintains Charles River(CRL.US) With Buy Rating, Maintains Target Price $265
Charles River (CRL) Teams Up to Aid Stargardt's Disease Therapy
Express News | Charles River to Perform Plasmid Manufacturing for Aavantgarde
Charles River to Perform Plasmid Manufacturing for AAVantgarde
Charles River (CRL) Could Be an Apt Pick Right Now: Here's Why
Charles River Labs Downgraded at Argus on Cautious Biotech Spending
These Nike Analysts Are No Longer Bullish; Here Are Top 5 Downgrades For Friday
Demystifying Charles River: Insights From 4 Analyst Reviews
Argus Research Downgrades Charles River(CRL.US) to Hold Rating